Neuroplast B Vis A Dutch Biotechnology Company Focused On Neuro Regenerative Medicineit Specializes In Developing Autologous Stem Cell Therapies To Treat Neurodegenerative Diseasesincluding Spinal Cord Injuriesalsand Dementiathe Company Aims To Address Conditions With Limited Treatment Optionstargeting Shared Degenerative Pathways That Affect Millions Globally One Of Neuroplast S Key Products Is Neuro Cellsa An Innovative Stem Cell Therapy Designed To Halt Or Reverse Neurodegeneration Using The Patient S Own Stem Cellsthe Company Has Received European Orphan Disease Designations For Spinal Cord Injury And Frontotemporal Dementiaand It Is Actively Advancing Its Clinical Trialsincluding A Recently Completed Phase 2 Trial For Spinal Cord Injuries With A Small Team Based In Geleennetherlandsneuroplast Is Positioned In The Multi Billion Dollar Neurodegenerative Disease Marketthe Company Is Dedicated To Expanding Its Clinical Pipeline And Developing Scalablepatient Specific Therapies To Meet The Growing Demand For Effective Neuro Regenerative Treatments
No conferences found for this company.
| Company Name | Neuroplast Bv |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
